Concerns over public health policies are intensifying as critics question the direction of nicotine regulation. A controversial report has been accused of misrepresenting scientific evidence on nicotine and its effects. Experts argue that key claims—such as equating vaping with smoking risks—are unsupported or misleading. The debate highlights tensions between regulatory approaches and harm reduction strategies, particularly in Europe. At its core lies a broader question of whether current policies are driven by evidence or ideology.

Lawmakers in Iowa are moving to introduce a new tax on alternative nicotine products, signaling a shift in how these categories are regulated. The proposal sets a 5-cent levy on nicotine pouches and a per-milliliter tax on e-liquids used in vaping products. The measure would apply broadly across both disposable devices and refill systems, creating a more uniform approach to taxation. Supporters argue the policy is aimed at generating funding for pediatric cancer research rather than significantly reducing usage. Critics, however, question whether such a modest tax can meaningfully influence consumer behaviour or public health outcomes.

A newly proposed EU Tobacco Excise Directive revision suggests a 400% tax increase on Swedish nicotine pouches. Despite being lower than previous proposals, it remains a significant hike. The Swedish government and manufacturers argue that the tax treats pouches like cigarettes instead of considering their lower harm. While the compromise aims to modernize regulations for various tobacco products, Sweden's successful harm-reduction model could be compromised. Concerns about the impact on consumers and illicit trade have stalled negotiations. Swedish stakeholders are urged to resist these tax increases, emphasizing the need for a risk-based tax framework.